Diabetes Clinical Trials in Georgia

Showing 181-200 of 528 trials

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

NCT03724981

In this study participants will try out two different types of drug injection pens (dulaglutide and semaglutide) on a practice pad and decide which device they prefer. No study drug will be administered.

Diabetes Mellitus, Type 2

Eli Lilly and Company312 participantsStarted Oct 2018

Fresno, California, United States • Long Beach, California, United States • Palm Harbor, Florida, United States +11 more locations

COMPLETEDNA65 miles

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

NCT04020822

The purpose of Phase 3 Group is to evaluate the impact of acetaminophen on the performance of Guardian Sensor (3) during 11 days of wear (approximately 264 hours) in subjects with insulin requiring diabetes,18-75 years of age.

Type 1 DiabetesType 2 Diabetes

Medtronic Diabetes19 participantsStarted Jul 2019

Aurora, Colorado, United States • Atlanta, Georgia, United States

COMPLETEDNA65 miles

ACR | LAB Urine Analysis Test System Evaluation of Performance

NCT04466501

The ACR LAB is a prescription-only, nurse- or clinician-conducted in vitro diagnostic (IVD) device. The test is for the qualitative and semi- quantitative detection of Albumin, Creatinine, and the Albumin-to- Creatinine Ratio. The device is composed of a kit and a smartphone application using an image recognition algorithm. The degree of agreement of the ACR \| LAB as compared to the comparator device will be tested. Urine samples will be tested by a separate professional user on each device.

DiabetesHypertension

Healthy.io Ltd.375 participantsStarted Jun 2019

Atlanta, Georgia, United States • Lexington, Kentucky, United States • Garden City, New York, United States

PreviousPage 10 of 27Next

A Study Comparing the Dulaglutide Pen and the Semaglutide Pen

Feasibility Study of New Subcutaneous Glucose Sensor With Recording Devices

ACR | LAB Urine Analysis Test System Evaluation of Performance

Diabetes Trials in Other Cities

Glargine U300 Hospital Trial

Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin

G-Pen™ Compared to Lilly Glucagon for Hypoglycemia Rescue in Adults With Type 1 Diabetes

Efficacy, Safety, and Tolerability Study of Sotagliflozin as Adjunct Therapy in Adult Patients With Type 1 Diabetes Mellitus Who Have Inadequate Glycemic Control With Insulin Therapy

An Observational Study to Understand Challenges Associated With Progression of Insulin Therapy in Type 2 Diabetes

Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

Effect of Gelesis200 on Body Weight in Overweight and Obese Subjects w/o Type 2 Diabetes

A Study of Once-Daily NNC0090-2746 in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Type 1 Diabetes and the Brain in Children

Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus

Rituximab in New Onset Type 1 Diabetes

Safety, Pharmacokinetics and Efficacy of Bimagrumab in Overweight and Obese Patients With Type 2 Diabetes

Patient and Provider Assessment of Lipid Management Registry

Bempedoic Acid + Ezetimibe Fixed-Dose Combination (FDC) Study in Patients With Type 2 Diabetes and Elevated LDL-C

CS02 vs Placebo With Metformin in Type 2 Diabetes Mellitus (T2DM)

4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes

An International Survey of the Occurrence of Cardiovascular Disease Among Patients With Type 2 Diabetes

Other Conditions in Georgia